Release 4B Ballot #1

This page is part of the FHIR Specification (v4.1.0: Release 4B Ballot #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Medicationadministration0305

Pharmacy Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: Device, Encounter, Patient, Practitioner, RelatedPerson

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile MedicationAdministration.

Generated Narrative

instantiates: http://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Lymphoma-Myeloma/ULYBRENTUX%20Protocol_1Jun2017.pdf

status: completed

medication:

code: Adcetris

manufacturer: Generated Summary: active; name: Acme Corporation

form: Lyophilized powder for injectable solution (qualifier value)

Batches

-LotNumberExpirationDate
*123452019-10-31

subject: Donald Duck. Generated Summary: Medical record number: 654321 (USUAL); active; Duck Donald (OFFICIAL); gender: male

context: encounter who leads to this prescription. Generated Summary: id: v1451 (OFFICIAL); status: finished; ambulatory; Patient-initiated encounter; Non-urgent cardiological admission; Heart valve replacement

effective: 15 Jan. 2015, 2:30:00 pm --> 16 Jan. 2015, 12:30:00 am

Performers

-Actor
*Patrick Pump. Generated Summary: id: 874635264 (OFFICIAL), id: 567IUI51C154 (USUAL); Simone Heps (OFFICIAL); Phone: 020556936, S.M.Heps@bmc.nl, Fax: 0205669283; gender: female; birthDate: 1971-11-07

request: Generated Summary: id: 12345689 (OFFICIAL); status: completed; intent: order; ?ngen-3; authoredOn: 2015-01-15; instantiatesUri: http://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Lymphoma-Myeloma/ULYBRENTUX%20Protocol_1Jun2017.pdf

Dosages

-TextRouteDoseRate[x]
*1.8 mg/kg IV infusion over 30 minutesIntravenous1.8 mg/kg20 min

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.